Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

0.0%

0 terminated out of 38 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

11%

4 trials in Phase 3/4

Results Transparency

21%

5 of 24 completed with results

Key Signals

5 with results100% success

Data Visualizations

Phase Distribution

23Total
Not Applicable (17)
P 1 (1)
P 2 (1)
P 3 (1)
P 4 (3)

Trial Status

Completed24
Unknown6
Recruiting4
Not Yet Recruiting2
Withdrawn1
Active Not Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 24 completed trials

Clinical Trials (38)

Showing 20 of 20 trials
NCT06997198Phase 4Recruiting

Deutetrabenazine Treatment for Tardive Dyskinesia in Intellectual/Developmental Disabilities

NCT07591636Not Yet Recruiting

ACT Dad Interview: ACT for Fathers of Children With Special Needs

NCT07524192Not ApplicableRecruiting

A Self-Instructional Online Program for Early Childhood and Elementary Teachers Supporting Autistic Children and Children With Developmental Delays

NCT06668519Recruiting

Magnetoencephalography in Children

NCT07459010Not ApplicableNot Yet RecruitingPrimary

ACT Dad's Power: Feasibility RCT for Fathers of Children With Special Needs

NCT06458959Not ApplicableActive Not RecruitingPrimary

Exploratory Trial of a Pediatric Web-Based Care Planning Guide

NCT06107829Phase 4Withdrawn

Valbenazine Treatment of Tardive Dyskinesia in Adults With Intellectual/Developmental Disabilities

NCT06532721RecruitingPrimary

Child Development and Genetic Biomarkers(II): Gene Verification and Data Integration

NCT03447119Not ApplicableCompleted

Living Well With a Disability Curriculum Adaptation Evaluation Plan

NCT01882153Not ApplicableCompleted

Evaluating Parent Delivered Interventions for Children With Autism

NCT02561754Not ApplicableCompletedPrimary

Weight Management for Adolescents With IDD

NCT02745990Not ApplicableUnknownPrimary

Recombinant Human Erythropoietin Improve Neurodevelopmental Outcomes in Extremely Preterm Infants

NCT02792894Not ApplicableCompleted

Family Networks (FaNs) for Children With Developmental Disorders and Delays

NCT02509936Not ApplicableCompleted

Promoting Physical Growth and Positive Development in Severely Stunted Guatemalan Children

NCT02714868Not ApplicableCompleted

Evaluation of Project TEAM (Teens Making Environmental and Activity Modifications)

NCT02495025Not ApplicableCompleted

Testing the Effectiveness of Telephone-based Early Childhood Developmental Screening

NCT01204151Not ApplicableCompletedPrimary

Teaching Math Skills to Individuals With Fragile X Syndrome

NCT02057809CompletedPrimary

"Family-centered" Pediatric Rehabilitation Services in Children With Developmental Disabilities

NCT02686931UnknownPrimary

The Investigation of Children With Developmental Delay and Children's Rehabilitation Common Case

NCT00106652Completed

Childhood Autism Risks From Genetics and the Environment (The CHARGE Study)

Scroll to load more

Research Network

Activity Timeline